Get started
Author

Thomas A. Murray

Observed names: Murray T, Murray, Thomas A, Murray, Thomas A., T Murray, T. Murray, THOMAS A. MURRAY, THOMAS Murray, Thomas A. Murray, Thomas A Murray, Thomas A. Murray, PhD, Thomas Murray
Observed institutions: University of Copenhagen, Regions Hospital, University of Minnesota, The University of Texas MD Anderson Cancer Center, Duke University, Vanderbilt University, University of Michigan, North Memorial Medical Center, University of Minnesota System, Rhode Island Hospital, Miriam Hospital, Hennepin County Medical Center, Baylor University Medical Center, Rigshospitalet, Cancer Research And Biostatistics, VA Tennessee Valley Healthcare System, Heart Hospital Baylor Plano, Duke Medical Center, North Memorial Health Care, Centre of Excellence for Health, Immunity and Infections, American Association for the Surgery of Trauma, Data Management (Italy), Indiana University Indianapolis, Vanderbilt University Medical Center
ORCID: 0000-0003-2769-4957
Observed ORCID: 0000-0003-2769-4957
OpenAlex ID: A5000250373
Advanced reperfusion strategies for patients with out-of-hospital cardiac arrest and refractory ventricular fibrillation (ARREST): a phase 2, single centre, open-label, randomised controlled trial
2020 · Demetris Yannopoulos, Jason Bartos, et al. · The Lancet · 1,070
Long Interdialytic Interval and Mortality among Patients Receiving Hemodialysis
2011 · Robert N. Foley, David T. Gilbertson, et al. · New England Journal of Medicine · 444
Metformin and risk of mortality in patients hospitalised with COVID-19: a retrospective cohort analysis
2020 · Carolyn T Bramante, Nicholas E Ingraham, et al. · The Lancet Healthy Longevity · 291
PDF
Randomized Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19
2022 · Carolyn T. Bramante, Jared D. Huling, et al. · New England Journal of Medicine · 240
Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): a multicentre, randomised, quadruple-blind, parallel-group, phase 3 trial
2023 · Carolyn T Bramante, John B Buse, et al. · The Lancet Infectious Diseases · 228
PDF
Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial
2022 · Thomas L. Holland, Adit A. Ginde, et al. · The Lancet Respiratory Medicine · 123
PDF
Comparative review of novel model‐assisted designs for phase I clinical trials
2018 · Heng Zhou, Thomas A. Murray, et al. · Statistics in Medicine · 86
A multi-center phase II randomized clinical trial of losartan on symptomatic outpatients with COVID-19
2021 · Michael A. Puskarich, Nathan W. Cummins, et al. · EClinicalMedicine · 67
PDF
Targeting the intracellular immune checkpoint CISH with CRISPR-Cas9-edited T cells in patients with metastatic colorectal cancer: a first-in-human, single-centre, phase 1 trial
2025 · Emil Lou, Modassir S Choudhry, et al. · The Lancet Oncology · 61
The Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen Level and Outcomes in Patients Hospitalized With COVID-19
2022 · ACTIV-3/TICO Study Group, Angela J. Rogers, et al. · Annals of Internal Medicine · 60
PDF
Efficacy of Losartan in Hospitalized Patients With COVID-19–Induced Lung Injury
2022 · Michael A. Puskarich, Nicholas E. Ingraham, et al. · JAMA Network Open · 58
PDF
A Bayesian Machine Learning Approach for Optimizing Dynamic Treatment Regimes
2017 · Thomas A. Murray, Ying Yuan, et al. · Journal of the American Statistical Association · 57
Should they stay or should they go? Who benefits from interfacility transfer to a higher-level trauma center following initial presentation at a lower-level trauma center
2019 · Tessa Adzemovic, Thomas Murray, et al. · The Journal of Trauma: Injury, Infection, and Critical Care · 52
Favorable Antiviral Effect of Metformin on SARS-CoV-2 Viral Load in a Randomized, Placebo-Controlled Clinical Trial of COVID-19
2024 · Carolyn T Bramante, Kenneth B Beckman, et al. · Clinical Infectious Diseases · 49
PDF
Renin‐Angiotensin System Inhibitors in Patients With COVID‐19: A Meta‐Analysis of Randomized Controlled Trials Led by the International Society of Hypertension
2022 · Sonali R. Gnanenthiran, Claudio Borghi, et al. · Journal of the American Heart Association · 49
PDF
Optimization of Spinal Cord Stimulation Using Bayesian Preference Learning and Its Validation
2021 · Zixi Zhao, Aliya Ahmadi, et al. · IEEE Transactions on Neural Systems and Rehabilitation Engineering · 42
Semiparametric Bayesian commensurate survival model for post‐market medical device surveillance with non‐exchangeable historical data
2013 · Thomas A. Murray, Brian P. Hobbs, et al. · Biometrics · 36
Outpatient treatment of Covid-19 with metformin, ivermectin, and fluvoxamine and the development of Long Covid over 10-month follow-up
2022 · Carolyn T. Bramante, John B. Buse, et al. · medRxiv · 34
PDF
Rationale and methods of the Advanced R2Eperfusion STrategies for Refractory Cardiac Arrest (ARREST) trial
2020 · Demetris Yannopoulos, Rajat Kalra, et al. · American Heart Journal · 34
PDF
Design and implementation of an international, multi-arm, multi-stage platform master protocol for trials of novel SARS-CoV-2 antiviral agents: Therapeutics for Inpatients with COVID-19 (TICO/ACTIV-3)
2021 · Daniel D Murray, Abdel G Babiker, et al. · Clinical Trials · 33
PDF
Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19
2022 · ACTIV-3/TICO Study Group*, Christina Barkauskas, et al. · Annals of Internal Medicine · 31
PDF
Robust Treatment Comparison Based on Utilities of Semi-Competing Risks in Non-Small-Cell Lung Cancer
2016 · Thomas A. Murray, Peter F. Thall, et al. · Journal of the American Statistical Association · 31
A Novel Model Incorporating Pectoralis Muscle Measures to Predict Mortality After Ventricular Assist Device Implantation
2019 · Rebecca Cogswell, Barry Trachtenberg, et al. · Journal of Cardiac Failure · 28
Morbidity and Mortality Trends of Pancreatitis: An Observational Study
2021 · Nicholas E. Ingraham, Samantha King, et al. · Surgical Infections · 27
Utility‐based designs for randomized comparative trials with categorical outcomes
2016 · Thomas A. Murray, Peter F. Thall, et al. · Statistics in Medicine · 27
Works count: 117
Citation count: 3,844
H-index: 27
I10-index: 38
Year
Topic
Type